World Congress on
Bioavailability & Bioequivalence: BA/BE Studies Summit
Scientific Program
Sumedh Gaikwad
Merck Group, Germany
Title: NTI (Narrow Therapeutic Index) drugs and BA/BE study-current challenges
Biography:
TBA
Abstract
TBA
- Emerging Bioavailability & Bioequivalence Studies
- Advances in BA&BE
- BA/BE of Biologic & Biosimilar
- Drug Metabolism
- New Approaches to Beat Multi-Drug Resistance: Natural and QSAR-designed Antimicrobial Peptides
- Bioequivalence Protocol: In-Vitro / In-Vivo Studies
- Biopharmaceutics Applications & Clinical Pharmacology
- Pharmaceuticals Formulation
- Pharmacology: PK & PD approach
- Vaccines, Blood & Biologics
- Public Health and Nutrition
- Regulatory Requirement and Approaches
- Pharmaceuticals Industry: Entrepreneur Meet
